Yoon S. Choi

Yoon S. Choi

Seoul St. Mary's Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 147 publications

Donor and stem cell source selection in hematopoietic cell transplantation in the Asia-Pacific region: results from the APBMT Activity Survey 2022-2023.

Donor and stem cell source selection in hematopoietic cell transplantation in the Asia-Pacific region: results from the APBMT Activity Survey 2022-2023.

Journal: Blood cell therapy

Published: April 03, 2026

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

Journal: Haematologica

Published: February 25, 2026

Baseline platelet-to-lymphocyte ratio is associated with severe immune effector cell-associated toxicities in diffuse large B-cell lymphoma patients receiving anti-CD19 CAR T-cell therapy.

Baseline platelet-to-lymphocyte ratio is associated with severe immune effector cell-associated toxicities in diffuse large B-cell lymphoma patients receiving anti-CD19 CAR T-cell therapy.

Journal: Frontiers in immunology

Published: October 24, 2025

Leukemic Presentation of CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review.

Leukemic Presentation of CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review.

Journal: Annals of clinical and laboratory science

Published: September 17, 2025

Corrigendum to: Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021 [Blood Cell Therapy. 2024; 7(4): 129-137. doi:10.31547/bct-2024-020].

Corrigendum to: Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021 [Blood Cell Therapy. 2024; 7(4): 129-137. doi:10.31547/bct-2024-020].

Journal: Blood cell therapy

Published: September 10, 2025

Prognostic Factors for Relapse and the Role of Maintenance Therapy in Acute Promyelocytic Leukemia: A Real-World Multicenter Study in Korea.

Prognostic Factors for Relapse and the Role of Maintenance Therapy in Acute Promyelocytic Leukemia: A Real-World Multicenter Study in Korea.

Journal: Cancer research and treatment

Published: August 26, 2025

Assessment tools for peripheral neuropathy in multiple myeloma.

Assessment tools for peripheral neuropathy in multiple myeloma.

Journal: The Korean journal of internal medicine

Published: August 15, 2025

Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide.

Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide.

Journal: Cancer research and treatment

Published: April 17, 2025

Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea.

Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea.

Journal: Cancer research and treatment

Published: April 10, 2025

Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.

Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.

Journal: Blood research

Published: April 08, 2025

Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease.

Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease.

Journal: The Korean journal of internal medicine

Published: January 12, 2025

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.

Journal: Blood research

Published: October 02, 2024

Showing 1-12 of 147

Last Updated: 09/26/2026